Objective To test the efficacy of Infliximab, a chimeric monoclonal antibody against TNF-α, in
the treatment of Takayasu arteritis. Materials and methods We used infliximab at an initial …

Objective. To analyse the efficacy and tolerance of infliximab in refractory Takayasu arteritis
(TA). Methods. French multicentre retrospective study that included patients with TA. Clinical …

The objective of this study was to report the long-term use of tumor necrosis factor (TNF)
inhibitors in case series of patients with Takayasu's arteritis refractory to standard …

Takayasu arteritis (TA) is a chronic inflammatory disease of large arteries which
progressively develop stenosis, occlusion or aneurismal degeneration. Proinflammatory …

We have experienced a Takayasu arteritis (TA) patient, successfully treated with infliximab,
who did not respond well to conventional therapy with glucocosteroid and methotrexate …

Objective: To assess the efficacy of anti-tumour necrosis factor (TNF) therapy to induce
remission in patients with Takayasu arteritis (TAK) refractory to other immunosuppressive …

SIR, Takayasu arteritis (TA) is a chronic, idiopathic, inflammatory disease that primarily
affects large vessels [1]. The management of this disorder is largely unresolved, since a …

Objective To report a single‐center experience with the use of tumor necrosis factor (TNF)
inhibitors in patients with Takayasu arteritis (TA). Methods We retrospectively studied a …

Abstract Treatment of Takayasu's arteritis remains a demanding challenge to clinicians. In
many patients the course of the disease is characterized by frequent relapses and disease …

Objective To compare the treatment outcomes of TNF inhibitors and tocilizumab (TCZ) in
patients with Takayasu arteritis. Methods Takayasu arteritis patients who were refractory to …